CMS National Coverage Determination (NCD)

CMS Cytogenetic Studies Form

Effective Date

07/16/1998

Last Reviewed

NA

Original Document

  Reference



Background for this Policy

The term cytogenetic studies is used to describe the microscopic examination of the physical appearance of human chromosomes.

Medicare covers these tests when they are reasonable and necessary for the diagnosis or treatment of the following conditions:

  • Genetic disorders (e.g., mongolism) in a fetus; (See the Medicare Benefit Policy Chapter 15, "Covered Medical and Other Health Services," §20.1)
  • Failure of sexual development;
  • Chronic myelogenous leukemia;
  • Acute leukemias lymphoid (FAB L1-L3), myeloid (FAB M0-M7), and unclassified; or
  • Mylodysplasia